Which stocks are best to look at in April 2021?

  Highlights COVID-19 ARDS stemming from COVID-19 infection is a leading cause of death among COVID-19 patients. Mesoblast Limited (ASX: MSB) is developing and testing remestemcel-L for reducing the mortality occurring due to COVID-19 ARDS in adults. As a next step, the company is expected to resubmit the current Biologic License Application (BLA) with a six-month review period. Rising coronavirus cases are increasing, posing a grave threat, especially in Queensland and Western Australia, as the number of cases topped 800 in the past few days. However, with the surge in COVID-19 cases, diseases or symptoms arising from the infection also take a toll on humans. For example, In COVID-19 ARDS (Acute Respiratory Distress Syndrome), the organs are deprived of oxygen as the air-sacs of the lungs are filled with fluids. ARDS has been identified as the leading reason for death for ventilator-dependent COVID-19 patients. Mesoblast Limited ( ASX: MSB ) is an Australian biopharmaceutical comp...

Some investors are inclined towards regular cashflows from their investments in the form of  dividend . When a company makes a profit, it shares a part of those profits with the  shareholders , which is called a dividend. However, companies are not obligated to pay dividends despite a profit. Also, the payout ratio, which is how much dividends are to be paid out of profits is decided solely by the management of the company. Most of the times, a company does not distribute all of its profits in the form of dividends as, some part has to be retained for future needs.   Image Source: Copyright © 2021 Kalkine Media Investors prefer dividends mainly because of two reasons. First, it is a passive source of income, and second, it provides a margin of safety for the investment by the amount of dividends received. For example, if an investor receives AU$5 dividend on a AU$100 share, they would still be at breakeven, despite the stock falling to AU$95, as they have already poc...

  Summary Stocks priced under 80 cents fall under the penny stocks category. These highly volatile stocks can offer significant upside potential. Although an attractive option for risk-takers, risk-averse investors generally stay away from penny stocks, given the high volatility attached. Some of the high-performing stocks priced under 80 cents include In the current period of uncertain economic scenario, share prices are fluctuating at a higher rate. The fluctuations are apparent given the high volatility, primarily due to the COVID-19  pandemic . However, there are some low-priced stocks, called  penny stocks , that are affordable and offer a ray of hope given their potential to offer impressive returns. These stocks do carry significant risk and thus are not appealing for all market participants. Copyright © 2021 Kalkine Media This article would walk you through 7 ASX-listed shares priced below 80 cents. GOOD TO KNOW:  How do I start trading penny stocks in Austra...

  If economy were a human body, banks would be its circulation system. That is the importance of banking in any economy. Banks, through the credit line, ensure that the economic engine of any geography keeps revving. That is not it, the banks help in the movement of money from surplus avenues to the places where they need it the most: they channelise the deposits and brand them as loans. That said, 2021 has been a year of ups and downs for the banking Industry. While the world has had its share of good and the bad news, banking stocks have steadily rallied in 2021, despite the big tech taking all the limelight. Take this example: the Dow Jones Banks index, which houses most of the Wall Street banks, has rallied by 25.03% on a year-to-date basis. This is despite the fact that the Archegos debacle had caused losses of about US$10 billion to some of the largest banks. But in the larger scheme of things, North America including the US, is not as important as it is perceived, when...

  COVID-19 times have been an exacting phase for businesses in Australia as well as across the globe. However, certain spheres, such as healthcare, have managed to make tremendous gains while others were in a tight spot. The metrics of the money market too reflect a similar picture for the   healthcare industry , particularly for its giants such as   ASX-listed CSL Limited. In mid-June 2021, CSL share price climbed over AU$300 for the first time in 2021. With this share price increase, CSL became Australia's priciest stock. Also, CSL shares had hit a 52-week high of AU$320.856 in November last year. As of 14 July 2021, CSL stock was trading at AU$279.6 at AEST 3:20PM and the company has a market capitalisation of AU$127.21 billion. Detailed Discussion at:  Most expensive stock on the ASX: CSL Limited shares shoot past AU$300 Image source: © Rcmathiraj | Megapixl.com CSL  Limited  – The ASX 200-listed biotechnology player CSL, a leading multinational biotech...